Stay updated with breaking news from Bioscience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s Q1 2024 earnings at ($0.07) EPS, Q2 2024 earnings at $0.00 EPS, […]
Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., Aug. 14, 2023 /PRNewswire/ -- INVO Bioscience, Inc. , a healthcare services fertility company focused on expanding access to... -Today at 04:06 pm- MarketScreener
-Harvesting underway for contracted winter and spring Camelina acres for the biofuels market-Reported positive results in first field tests of sta...
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced...
Gainers Amyris, Inc. (NASDAQ: AMRS) shares surged 45.4% to $0.0958 in pre-market trading. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy.